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Introduction  
 The term “Geriatric” refers to the ageing human population and 
“Geriatrics” refers to the medical field that deals with clinical problem specific to 
old age. Ageing is a universal process. In the words of Senica, old age is an 
incurable disease. Sir James Sterley lamented, You do not heal old age, you 
protect it, you promote it and you extend it.  
 As we watch with horror, as the hairline marches backwards to the top of 
the head, skin wrinkles like cellophane and memory diminishes, any one will ask, 
what it means to grow old. The answer from scientific committee may surprise us, 
“we don’t know”. Neither these definition nor the medical literature specify a 
precise age to delineate this group (Strausburgh et al  2001).  
 In 1900, only 1% of earthly population i.e, 15 million was greater than 65 
years of age. By 1992, 6% of global population or 342 million populations were in 
this category. By the year 2050 these figures will have grown to 20% and 2.5 
billion respectively. In India by 2050, 21% of the Indian population will be 60+. 
Expectation of life also increases as it is projected to be 67 years for males and 69 
years for females in 2011 – 2016 . (Maher & Raviglione 2005) 
 From the stand point of health care, the geriatric population is diverse. This 
people constitute a definable population who are at increased risk for nosocomial 
and other health care associated infections. Geriatric patients like transplant 
recipients may be compared to “Sentinel Chickens”, the first to be affected by new 
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or emerging infection in hospitals and other health care environments that care for 
adult patients.  
 The elderly have defective host defenses that compromise their ability to 
ward off infectious agents. Factors influencing immunocompetence includes 
immune senescence, changes in nonadaptive immunity, chronic diseases, 
medications, malnutrition and functional impairments. (Prakash et al 1999). 
Respiratory infections and gastroenteritis occur most frequently. Although no 
national data or frequency of occurrence are available, public health reports says 
that the occurrence was not uncommon. 
Elderly Tuberculosis  
“A forgotten germ returns revisiting the elderly with vengeance”                       
When today’s elderly were young, tuberculosis affects greater numbers of people. 
According to Park, about 65% of people within the age of 55 in India are affected 
with tuberculosis. It was viewed as a dreadful disease. Although the cause of the 
illness was already understood, the cure remains elusive not to arrive for at least a 
decade. Tuberculosis, although predominant among the poor and underfed and 
rampant among those living in unsanitary surroundings, did not discriminate.  
 Tuberculosis attack the young and middle age, and took its toll among 
healthy. Many individuals young at that time and making up the elderly group 
now, survive this nagging epidemic. Their immune system succeeded in fighting 
the germs to a draw. But the invader remains, content to live quietly in his host, 
 3
temporarily encapsulated by antibodies but awaiting the opportunistic moment for 
return. . The majority of pulmonary tuberculosis, in older people is due to 
inactivated diseases. In one study by Liaw et al (1995) about 26.2% of elderly 
tuberculosis patients suffer previous tuberculosis disease.  
        This present report deals with socioclinical dimension of elderly 
tuberculosis. 
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 Aim and Objectives 
1) To study the socio-demographic pattern of elderly tuberculosis. 
2) To analyze their clinical presentation and diagnostic aspects.{Radiological, 
microbiological, immunological, biochemical, hematological}, and 
3) To elicit co existing illness among them. 
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REVIEW OF LITERATURE 
Global Epidemiology of Tuberculosis  
 In 1993, the World Health Organization declared tuberculosis as a global 
emergency because of the scale of the epidemic and the urgent need to improve 
global tuberculosis control.  
 According to Tuberculosis case notification and rates by WHO in 2002, 
three regions dominates the world wise distribution & notification i.e., South East 
region 36%, African region 24% & Western Pacific region 20%. (Maher & 
Raviglione 2005).  
 In Industrialized countries, case notification of Tuberculosis, which 
approximated the true incidence of tuberculosis more closely than in developing 
countries, steadily declines throughout most of twentieth century in industrialized 
countries. This is because of socio economic improvement and possibly because of 
the isolation of the infectious cases in sanitoria. The effective application of 
chemotherapy in the later half of twentieth century further accelerated the decline. 
From the mid 1980 onwards several countries saw a expected continuous decline, 
with case notification increasing for the first time in many years. Factors 
responsible for the reversal of the previous trend include increased poverty among 
marginalized group in inner city areas, immigration from areas with high 
tuberculosis prevalence, the impact of HIV and the failure to maintain the 
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necessary public health infrastructure under the mistaken belief, tuberculosis was 
the disease of the past.  
 TABLE 1  TUBERCULOSIS CASE NOTIFICATION AND RATES BY 
WHO  REGION IN 2005  .  
WHO region No. of cases notified Proportion of global total (%) 
South East Asia 1,487,985 36 
Africa 992,054 24 
Western Pacific 806,112 20 
Americas 233,648 9 
Eastern Mediterranean 188,458 6 
European 373,497 5 
SOURCE:CLINICS IN CHEST MEDICINE 2005 
 In 2002, there was an estimated 8.8 million new cases of tuberculosis world 
wide, with an incidence rate of 141 per 1,00,000 population. 
Epidemiology of Tuberculosis in India  
 Tuberculosis continues to be a major public health problem in India. Since 
the national reporting system is defective, the only reliable source of information 
on the magnitude of the tuberculosis problem has been the population sample 
surveys.  
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 The only authentic survey on a country wide basis, is the national sample 
survey (1955 – 1958) conducted by ICMR. The National Tuberculosis Institute, 
Bangalore undertook three longitudinal surveys at Delhi, Bangalore and 
Chengelpet. India ranks first in the estimated number of Tuberculosis cases i.e, 
1,049,549 thousand cases. (Maher & Raviglione 2005).  
 The overall prevalence of infection (as judged by the standard tuberculin 
test) was about 30%, in males 35% and in females 25%. The prevalence was 4 
cases per 1,000 population. The incidence of new cases was about 1.5 per 1000 
population. According to experts it is safe to estimate that at least 50% of the 
population above the age of 20 years is infected and will remain at risk of disease 
throughout their lifetime (WHO 2002).   
Gender difference in tuberculosis  
 Little has been written about  gender differences in tuberculosis. In general, 
the notification rate is higher in men than women. Gender differences vary in 
different parts of the world. In their study, Chan-Yeung et al (2002) demonstrated 
that the tuberculosis rate was higher in men than in women in all age groups and 
the sex difference increases with age. In those aged 60 – 79 years, men are 
affected four times more than women.  
 Martinez et al(2000)  reported sex differences in the rate of tuberculosis in 
San Francisco(USA)  from 1991 – 1996, higher men : women ratio was observed. 
They suggested that the observed sex difference was due to differences in 
 8
transmission dynamics rather than diagnostic or reporting bias. Sutherland et al 
(1979) studied the risk of tuberculosis infection in the Netherlands from 1967 to 
1979 and found that there was no differences in the annual rate of infection 
between boys and girls aged 6 – 12 years. However for those between 12 – 18 
years, an excess in the annual rate of infection was found among males. 
Duration of illness  
 There is a delay in diagnosing TB in elderly patients. They present more 
commonly with non-specific complaints. Therefore the tuberculosis may not be 
suspected initially and there maybe considerable delay before the diagnosis and 
may present at the advanced stage of the disease and with multiple other medical 
problems.  
 In a study by Arora & .Bedi (1989) in Himachal Pradesh, it was found that 
only 40% of the elderly tuberculosis patients were aware that these symptoms 
would be due to Tuberculosis. Another study carried out by Liaw  et al (1995), in 
comparing clinical spectrum of tuberculosis in people less than & greater than 65 
years of age, reported that diagnosis of TB in first visit was made out in 47.3% in 
patients less than 65 years of age against 38.6% in patients greater than 65 years of 
age.  
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Pathogenesis & immunological aspects  
 The principal route of entry in tuberculosis is the lung. Inhaled tubercle 
bacilli are engulfed by alveolar macrophages and transported to regional lymph 
nodes. Infected macrophages and circulating monocytes secrete proteolytic 
enzymes, generating an exudative lesion and granuloma formation with activation 
of T cells. This leads to the onset of cell mediated immunity. The characteristic 
Ghon complex ultimately develops, tubercle bacilli ultimately restrain within 
caseous necrosis with eventual healing. A study by Zhmikrobiol et al (2002) 
reported that there is a decreased activity of natural killer cells in tuberculosis 
patients. The greatest decrease in the activity of natural killer cells was observed in 
patients with chronic fibro cavernous form of tuberculosis.  
 A study by Ashkin et al (1999) showed that elderly individuals are more 
likely to have concomitant illness that causes varying degrees of cellular 
immunodeficiency. It has long been known that patients with diseases such as 
diabetes, malignancies and renal diseases or who were receiving medications that 
suppress their cellular immunity were more likely to progress from TB infection to 
disease.  
 Interestingly, while these concomitant illnesses only produce a minor 
cellular deficiency, it is enough to make patients more susceptible to TB disease. 
Thus altered immune function might predispose the elderly to potential reinfection 
with TB.  
 10
 It is due to these defects in cellular immunity, elderly patients who present 
with a chronic wasting or respiratory illness may not present in the classic form.  
Clinical spectrum of Tuberculosis  
 Tuberculosis in older patients can present atypically. Approximately 75% 
of elderly persons with TB disease manifest lung involvement (Rajagopalan et al 
(2001)). Many older patients with tuberculosis disease may not exhibit the classic 
features of tuberculosis. Tuberculosis in the population may present clinically with 
changes in functional living, chronic fatigue, cognitive impairment, anorexic or 
unexplained low grade fever.  
 According to Chan et al (1995), cough was the most common symptom in 
both elderly and young tuberculosis patients. However non specific symptoms 
occur in 25% of the elderly tuberculosis patients. According to Chan et al (2002) 
systemic symptoms dominates the picture in elderly tuberculosis. As against them,  
Arora et al (1989) reported that ‘breathlessness’ was the most common symptom 
in elderly tuberculosis patients.  
 Clinical features of pulmonary tuberculosis in the young and elderly 
patients have been compared. Symptoms of tuberculosis like fever, night sweats, 
weight loss, sputum production & hemoptysis were significantly in lower 
proportion in the elderly group as compared to the young. Abnormal mentation 
was more common in the elderly. Katz et al (1987) found no significant difference 
in the presentation with symptoms of fever and weight loss among the elderly.  
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They observed that the elderly significantly present with hemoptysis, have 
cavitatory  lesions on radiographs. Elderly TB patients were more likely to present 
with dyspnoea as their main symptom. A reactive arthralgia has been described in 
some patients which can mimic a low degree, subacute rheumatoid arthritis. This 
is probably more common in people of Asian, African & Caribbean origin. Fever 
if present is usually low grade and is easily missed unless rectal temperature is 
measured in the late afternoon or evening (Brochlehurst et al 1992).  
Smoking and elderly Tuberculosis 
 “Some patients commit suicide by drowning but many by smoking”.  
 According to Arora et al (1989) about 68% of elderly tuberculosis patients 
are smokers & chronic bronchitis occurs in about 64% of elderly tuberculosis 
patients. This results in altered clinical presentation. The majority did not seek 
early medical relief as they attribute their complaints to old age and smoking.  
 According to a study from Udaipur about the morbidity pattern among 
elderly population by  Prakash et al (2004), about 63.6% of elderly people are non 
smokers and 37% are current or ex-smokers.  
 Cigarette smoking is responsible for 90% of chronic obstructive pulmonary 
diseases. Chronic mucous hyperplasias of the larger airway results in a chronic 
productive cough in as much as 80% of smokers over age 60 (Harrison16th 
edition).Since smoking is strongly related to elderly patients, these elderly 
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tuberculosis patients present late and they wrongly attribute these symptoms to 
chronic obstructive pulmonary disease.  
 In patients of both sexes over the age of 30 suffering from pulmonary 
tuberculosis, it has been shown by Lowe et al (1956) that there is a highly 
significant deficiency of non smokers and light smokers compared with controls of 
the same as suffering from other diseases. Kahn et al (1966) shown that mortality 
from pulmonary tuberculosis among doctors has been shown to increase 
significantly with the number of cigarette smoked and the similar effect has been 
also shown in investigations.   
Co morbid Illness 
 Disease associated with impaired cellular immunity such as Hodgkins’ 
disease, leukemia, lymphoma and AIDS may predispose to reactivation. Snider et 
al (1985) has shown gastrectomy probably predisposes to tuberculosis, particularly 
in patients with low weight / height ratios or malabsorption syndrome. Morrio et al 
(1992) has shown diabetes mellitus may predispose to tuberculosis and also lead to 
a significant increase in cavitation and smear positive disease. Chan et al (1998) 
reported that, chronic obstructive pulmonary disease was the commonest among 
medical condition in the elderly. He also showed about 9% of elderly tuberculosis 
patients are diabetics. . Arora et al (1989) have found lower sputum conversion 
and cure rates in elderly TB patients as compared to those of the younger age 
group. One of the reason he proposed as the cause of decreased cure rate was that 
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about 15 – 85% of elderly patients suffer from concomitant diseases like chronic 
bronchitis, emphysema, diabetes, etc and their presence would complicate both the 
diagnosis and treatment of TB.  
Diabetes & elderly tuberculosis 
 In most studies on this subject, persons with diabetes mellitus have two fold 
to four fold higher incidence of active tuberculosis than non-diabetic patients 
(Morse et al (1964). The predisposition of diabetes to infection that are normally 
controlled by cell mediated immunity may result from one or more defects of 
pulmonary host defense, including conditions that interfere with normal clearance 
mechanisms or that impair pulmonary function. The greatest difficulty in studying 
diabetes mellitus as an independent risk factor for the development of tuberculosis 
is the presence of potential confounding variables. These variables include other 
co-existent medical conditions (eg. malnutrition, chronic renal disease) and 
personal behaviors, such as smoking & alcohol that may further weaken host 
defenses.(Koziel et al (1998)) 
 Henry & Stableforth (1983) described this finding from a group of diabetic 
TB patients living in the United Kingdom as diabetic tuberculosis patients presents 
with a higher incidence of cavitatory disease and sputum positive states than did a 
control group of Non Asian diabetic TB patients. This was presumably due to 
higher exposure risk of the Asians which appeared to be associated with their 
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living in settings that replicate and concentrate the bacilli, the social behaviour and 
condition of their birth communities.  
Miliary Tuberculosis in elderly 
Miliary TB is very common in the elderly. This presentation occurs in 1 in 
20 cases.(Pathy 1993). It is one of the common causes of pyrexia of unknown 
origin in the elderly. Usually sputum will be negative for mycobacterium. 
According to Babrowitz et al (1982) miliary TB in the elderly can be particularly 
difficult to recognize. In patients over 80 years majority of military tuberculosis is 
undiagnosed and it is fatal. According to Robert et al (1974), the classical acute or 
sub acute high intermittent fever and early onset of complicating meningitis or 
serositis is often absent in the old. It presents as more chronic form of slowly 
progressing protracted, wasting illness with absent or low grade fever without any 
localizing symptoms or signs. Examination may reveal only a 
hepatosplenomegaly. Abnormal chest x-ray is quite compatible with miliary 
tuberculosis (Kulpati) 
Hematological abnormalities in elderly tuberculosis. 
Hematologic abnormalities, normocytic normochromic anemia, neutrophilia, high 
erythrocyte sedimentation rate & hypoalbuminia can occur & it is similar to those 
observed in younger patients. However anemia and lower white cell counts are 
more common in the elderly. A high incidence of drug induced neutropenia occurs 
in elderly TB. Kaltenbach et al (2001) compared the biochemical parameters 
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between elderly and young TB patients. He observed that the commonly observed 
biochemical abnormality was increased erythrocytic sedimentation rate (49 vs 65 
mm/h) & lymphocytopenia (1729 vs 1059 / µl , p < 0.01) which was also observed 
by Yokayama et al (2003). Yamaguchi et al (2003) stated that hypoalbunimia and 
neutrophilia was higher in the elderly group. In patients with military tuberculosis 
there is profound bone marrow suppression.  
Investigations in Tuberculosis 
Tuberculin Intradermal Test  
The tuberculin was discovered by Von Pirquet in 1907. A positive reaction to the 
test is generally accepted as evidence of present or past infection by M. 
tuberculosis. The tuberculin test is the only means of estimating the prevalence of 
infection in a population.  
Tuberculin – Now purified protein derivative is used. It contains 50,000 
tuberculin units per milligram. One TU is equal to 0.01 ml of O.T. or 0.0002 mg 
PPD (Youman et al 1980).  
Dosage  
a) First strength or 1 TU 
b) Intermediate strength or 5 TU 
c) The second strength or 250 TU. 
For routine testing, the vaccinating team in India use 1TU. (Comstoch et al 980.) 
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Mantoux test  
The mantoux test is carried out by injecting intradermally on the flexor surface of 
the fore arm 1 TU of PPD in 0.1 ml. The WHO advocates a preparation known as 
PPD – RT – 23 with Tween-80. The result of the test is read after 72 hours.  
In Tuberculin reaction induration is measured.  
  > 10 mm  Positive  
< 6 mm  Negative  
6 – 9 mm  Doubtful  
 
(Source : Park’s Preventive & social medicine, 18th edn.) 
A positive reaction indicates that the person is infected with M.tuberculosis, it 
does not prove that the person is suffering from the disease. (The Tuberculosis 
Association of India, New Delhi, 1981).  
An excellent but inadequately noticed paper by  Zybowski & Allen in 1964 
documents the phenomenon of reversal of tuberculin reaction to negative over 
time while the role of reversal varies with age. It was shown to continue for the 
life span at a rate of about 5% per year.  
There is data to suggest that the negative tuberculin reaction, which is often in 
elderly is mainly due to falling immune response to tuberculin antigen (Brande et 
al 1992).  
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According to Yokayama et al (2003) antibody to tuberculin skin test with purified 
protein derivative was evident in 7% of patient under 65 and 14% of those over 65 
years of age. 
Now the American Geriatric Society routinely recommends two step tuberculin 
tests as per the base line information of all institutionalized elderly. The two step 
test involves initial intradermal placement of 5 tuberculin units of PPD and the 
results are recorded at 48 – 72 hours. Patients are retested within 2 weeks after a 
negative response (induration of < 10 mm). The application of the second 
tuberculin skin test should be accompanied by dermal control antigen (i.e. candida, 
mumps or tetanus toxoid) diluted to a 1.5 concentration with phenol buffered 
diluent to assess the presence of anergy. A positive booster effect and therefore a 
positive tuberculin skin test reaction is a skin test of 10 mm or more and an 
increase of 6 mm or more over the first skin test reaction. The booster effect 
occurs in a person previously infected with M.tuberculosis but who has a false 
negative skin test, repeat test elicits a truly positive test. It is important to 
distinguish the booster phenomenon from a true tuberculin conversion. Conversion 
occurs in persons previously uninfected with M.tuberculosis and who had a true 
negative tuberculin test but who becomes infected within 2 years as demonstrated 
by a repeat skin test that is positive during this period. 15 mm or more is 
considered positive for a conversion activity in persons 35 years and older and in 
persons with no risk factors for tuberculosis (Hazzaro et al).  
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Chest X-ray 
The chest x-ray is mandatory in the diagnosis of Tuberculosis. The radiological 
features of tuberculosis in the elderly patients are often similar to those in younger 
patients but there is a greater prevalence of mid and lower zone shadowing 
(Umeki et al 1989).  
 According to Guzman et al (2000) atypical radiological images of 
pulmonary tuberculosis are common in elderly and in diabetic patients. The 
proportion of patients with lower lung fields lesions progressively increases with 
age where as the frequency of cavitations steadily decreases with age.  
 Guzman et al proposed that a higher frequency of lower lung disease in the 
elderly is due to immunological abnormality or to a higher frequency of 
pulmonary tuberculosis. Aging leads to increased alveolar ventilation and reduced 
perfusion resulting in increased mismatch and increased PAO2. These changes 
should affect the lower lobes more than the upper lobes because the latter have a 
higher ratio and higher PAO2. Therefore age induced changes should favour 
multiplication of Mycobacterium tuberculosis in lower lung zones. Further more 
frequency of upper lung field lesion (with or without lower lung field lesion) was 
similar at all ages, suggesting that aging does not alter condition in upper lobes. 
 According to Rizvi et al (2003) radiograph in elderly patients more 
commonly had extensive bilateral infiltration (32.4% Vs 14.9%) P<0.05) when 
compared with young. A similar view was experienced by Umeki et al (1989).  
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 According to Yamaguchi et al (2001) the frequency of cavitation was lower 
in the elderly group (59.67%) than the middle aged group (87.4%).  
 According to Chang et al (1998), elderly patients more frequently had 
extensive disease involving both lungs, particularly in the advanced age group of 
75 years and over. This may be caused by delay in presentation or poorer 
immunity in the elderly. Interestingly cavitation is less common in elderly patients 
probably reflecting a diminished cellular immune response with less tissue 
destruction. This may also explain why hemoptysis is less common in elderly 
subjects.  
Sputum examination  
Sputum examination for M.tuberculosis using smear and culture is indicated for all 
patients who have pulmonary symptoms and radiographic changes compatible 
with tuberculosis. Sputum examination is carried out by Ziehl Neelson & Kinyoun 
methods which utilizes the carbolfuschin method. Otherwise auromine rhodamine 
dyes are used with uses flurochrome methods.  
 For suspected tuberculosis, it is recommended that 3 fresh consecutive 
sputum specimen obtained in the morning be used for routine mycobacteriological 
study (American thoracic society, Diagnostic standards of classification of TB, 
2000).  
 For elderly patients who are unable to expectorate, flexible fibroptic 
bronchoscopy to obtain bronchial washings & bronchial biopsy specimens is 
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clearly feasible and is a valuable diagnostic option (Patel et al 1983). Patients who 
cannot produce sputum despite these measures may require gastric aspiration. 
Smear test for M.tuberculosis may require a minimum of 104-5 AFB per milliliter 
to be seen by light microscopy (Rajagopalan et al (2001)).  
 Arora et al (2003) compared sputum profile of tuberculosis between 
younger and geriatric patients. He demonstrated that the ratio smear positive to 
smear negative patients was almost similar in the two age groups. Further the 
treatment outcomes of new smear positive geriatric TB patients in comparison to 
younger patients showed lower sputum conversion (75.3% to 85.7%). This same 
view was endorsed by a study in Hong Kong where the bacteriologically 
confirmed pulmonary tuberculosis cases increases with age from 59.8% in those < 
20 years to 76.2% in those > 80 years. As against this Gaur et al (2004) showed 
that the percentage of elderly tuberculosis patients found to be bacteriologically 
positive by direct smear was 59.6% as compared to 65.8% among the comparison 
group (35 – 50 years).  
Culture  
Routine mycobacterial culture methods which use Lowenstein – Jensen medium 
may require up to 6 weeks for growth of mycobacterium tuberculosis. A recent 
Bactec System which utilizes liquid broth media containing the 14 C labelled 
palmitic acid specific for mycobateria allows culture in 2 weeks are an addition to 
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our armamentarium for the diagnosis of tuberculosis. These are not yet available 
for routine clinical practice (Kulpati ).  
Immunoassay for mycobacterial antigen, serological tests for tuberculosis 
and detection of mycobacterial components or products by high performance 
liquid chromatography, gas chromatography and mass spectrometry are also 
important.  
Henn et al (2001) evaluated the sensitivity and specificity of anti 
Lipoarabinomannan IgG antibodies for diagnosis of tuberculosis in cases of 
pulmonary, extra pulmonary or associated forms. She concluded that the test is 
easy and ideal for use in diagnosis of active tuberculosis in specific cases in 
conjugation with the other methods and permit to evaluate the humoral immunity. 
Rapid radiometric detection makes out mycobacterial growth (detection of 14 CO2 
released) in 10 – 12 days. A further advantage is that the DNA probe identification 
and antibiotic susceptibility tests can also be performed rapidly (Rajagopalan et 
al).  
Other tests  
Molecular techniques extend knowledge about TB. Genetic finger printing using 
restriction fragment length polymorphism patterns to identify isolates, have proved 
that HIV seropositive individuals and presumably other people as well can be       
re-infected by TB. Molecular epidemiology again using RFLP pattern has helped 
identifying transmission network that the traditional epidemiology failed to 
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identify. Early detection of drug resistance by rapid identification of genetic 
mutation and by chemiluminescent methods so called as “Fire fly”.  
Management of Elderly Tuberculosis.  
TABLE 2  Treatment categories in DOTS chemotherapy in India.  
Tuberculosis Treatment        
Regimen* Diagnostic 
Category 
Tuberculosis 
Patients 
Initial Phase 
Continuation    
Phase  
Category I 
a) New sputum smear positive 
b) Seriously ill – smear negative 
c) Seriously ill – extra pulmonary  
2 (HRZE)3 4 (HR)3 
Category II  
a) Sputum smear positive relapse**  
b) Sputum smear positive failure**   
c) Sputum smear positive after 
 default. 
 
2 (HRZES)3 
 
1 (HRZE)3 
 
 
5 (HRE)3 
Category III 
a) Sputum smear negative not 
 seriously ill 
b) Extra pulmonary not seriously ill. 
 
2 (HRZ)3 
 
     4 (HR)3 
 
* The number before the letter refers to the number of months of treatment. 
The subscript after the letter refers to the number of doses per week. 
** In rare and exceptional cases, patients who are sputum smear negative or 
who have extra pulmonary disease can have relapse or failure. This 
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diagnosis in all such cases should be made by a medical officer and should 
be supported by culture and histological evidence of current, active 
tuberculosis. In these cases the patient should be categorized as others and 
given category II treatment. (Source : Park’s Preventive and social 
medicine 18th edition).  
 Drug       Adverse Reactions  
1. INH    GIT irritation, peripheral neuropathy*, blood  
     dyscrasias, hyperglycemia & liver damage**. 
2. Rifampicin   Hepatotoxicity, Gastritis, Influenza like illness,  
     purpuric thrombocytopenia & nephrotoxicity. 
3. Streptomycin   Vestibular damage, nephrotoxicity.  
4. Pyrazinamide   Hepatotoxicity, Hyper uricemia  
5. Ethambutol    Retro bulbar neuritis.  
(Source : Park’s Preventive & social medicine, 18th edition) 
* Peripheral neuropathy can be prevented by pyridoxine 10 – 20 mg daily.  
** A transient rise in serum enzymes to three times the normal may occur 
during  INH therapy. 
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Therapeutic difficulties in elderly patients  
 Whatever the age, the main cause of treatment failure is the lack of 
compliance especially among elderly patients. Old age dementia, mental 
confusion, depression, lack of eye sight fails them in taking particular drug at right 
time in right dosages. Elderly people due to the absence of effective 
reinforcement, they lack the determination required to complete course and 
treatment (Ritasood 2003). Older people are more prone for drug reaction when 
compared with young people. This same hypothesis also applies to elderly 
tuberculous patients. Tealc et.al (1993) stated that the elderly people are 3 times 
more likely to have reaction to antituberculous drugs as compared to young 
patients. Pande et al 1996 reported that hepatotoxicity due to INH and rifampicin 
was very common in elderly tuberculosis patients. Rifampicin combined with 
1NH has additional hepatotoxic effects. As renal function, hearing acuity, 
vestibular function declines with aging, ototoxicity and nephrotoxicity due to 
streptomycin is more in elderly patients when compared with younger patients. 
Since some visual impairment is common in the elderly, a careful examination that 
includes visual acuity and color discrimination should be performed before 
initiating ethambutol therapy. Drug interactions must also be considered. Patients 
may be taking other drugs for other illness which may interact with 
antituberculosis drugs.  
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 Other social factors, like lack of transport facility, inability of the service 
provider to visit regularly, lack of financial support, loneliness are also other 
reasons for increased default rate. 
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Materials and Methods 
Study Design  : Cross Sectional Study  
Setting   : Govt. Rajaji Hospital, Madurai 
Period of study : January 2005 to December 2005 
Ethical clearance : Ethical committee approved the methodology of the study  
                                             and copy enclosed in annexure I 
Consent   : Consent was obtained from all the patients considered for the  
                                             current study. 
Financial support : Nil  
Conflict of interest : Nil  
Inclusion Criteria 
Patients who satisfied the following were included in the study.  
1) Elderly patients (above 60 years of age) who were sputum smear positive, 
or with clinical and radiological profile suggestive of tuberculosis were 
included in the study. 
2) Both sexes. 
3) HIV negative status. 
4) Willing & Co-operative individuals.  
Exclusion Criteria 
Patients who had any one of the following or a combination of them were 
excluded.  
1) More seriously sick individuals.  
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2) HIV co-infection. 
3) On immunosuppressive therapy. 
4) Associated malignancy 
5) Major abdominal / thoracic surgery. 
6) Un-cooperative / unwilling patients  
7) Major cardiac illness 
8) Collagen vascular diseases 
9) Occupational diseases  
10) Extra pulmonary tuberculosis.  
METHODS  
Selected socio-demographic, clinical and laboratory data were elicited from the 
patients and recorded in a proforma (enclosed in annexure II). 
I.Socio demographic data:  
a) Age        b) Sex       c) Address       d) Contacts    e) Number of family members 
II. Clinical data 
a) Body weight        b) Height       c) Pulse rate       d) Blood pressure    e) Clinical 
examination 
III. Laboratory data 
a)  Hemoglobin: measured using Sahli’s hemoglobinometer.         
b)  Total count & Differential count   using Leishmann stain.      
c)  Blood urea done manually by using Diacetyl monoxime technique.        
d)  Serum creatinine: estimation done using COBAS auto analyzer.     
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e)  Blood glucose: estimation done using glucose oxidase method 
f)  putum AFB: 3 early morning specimens collected and stained by Ziehl –
Neelson     technique 
g)  X-ray Chest: PA view was taken in a radiation dosage of 0.02mSv. 
The following definitions were used in this study. 
Ex-Smoker: Patient who ceases smoking for 2 years.(Changes in the small 
airways of smokers will reverse after 1- 2 years of cessation) (Harrison               
16th edition) 
Diabetes Mellitus:  
a) Fasting plasma glucose ≥126 mg/dl 
b) Two hour plasma glucose ≥200 mg/dl in oral glucose tolerance test. 
c)  Symptoms of diabetes plus random blood glucose concentration  ≥ 200  
 mg/dl 
Hypertension: Systolic ≥ 140 
                        Diastolic  ≥ 90 
   Based on the average of ≥ 3 reading, when any one of the value (systolic or 
diastolic BP) is less than the above given value but the other value is higher, the 
higher value is taken into consideration. 
Anemia: Anemia is defined as a decrease in the circulating RBC mass, the usual 
criteria are a hemoglobin of less than 12 g/dl in women and less than 14 g/dl in 
men. 
Body Mass Index: Weight in kilogram / Height in m2 . 
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X-ray zones: The chest x-ray was divided into three zones. 
                        Upper zone: 1st and 2nd intercostal space. 
                        Middle zone: 3rd and 4th intercostal spaces. 
.                       Lower zone: Rest of the intercostal spaces. 
Limitations of the study 
1) Age and sex matched control was not attempted since only one disease was 
taken into consideration.   
2) Over all outcome is not measured since all subjects living outside Madurai 
were referred to concerned DOTS centre for drug treatment.  
3) Pulmonary function test was not done.  
4) Induced sputum was not attempted, as it was not approved by the 
institutional ethical committee. 
5) Since single group of patients were analyzed, complex statistical analysis 
was not done.  
6)        Therapeutic aspects, drug toxicity and follow up of these aspects were not 
considered as they were beyond the scope of the objectives. 
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RESULTS 
A total of 90 patients were studied. The distribution of cases in relation to age 
 and gender is furnished in table 3.  
TABLE 3:  DISTRIBUTION OF SUBJECTS ACCORDING TO AGE &  
GENDER 
 
MALE FEMALE  
AGE (in years) 
No. % No. % 
TOTAL 
60 – 69 54 (56) 75 18 (16) 25 72 
70 and above  16 (14) 89 2 (4) 11 18 
Total   70 78 20 22 90 
 
The numbers in the brackets indicates expected values.  
Using chi-square test, it was found the difference between age and sex was not 
significant. Thus, the distribution of age and sex are independent in this study. The 
details are given in figure 1. 
 
 The distribution of subjects according to duration of illness and gender is 
provided in table 4.  
TABLE – 4   DURATION OF ILLNESS AND GENDER.  
 
MALE FEMALE  TOTAL DURATION OF 
ILLNESS No. % No. % No. % 
< 3 Months  39 (56) 55 9 (45) 45 48 53 
3 – 6 Months  12 (57) 17 6 (30) 30 18 20 
> 6 Months  19 (27) 27 5 (25) 25 24 27 
The numbers in the bracket indicates expected values.  
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This table number 4 shows that majority of the male subjects (55%) presented 
with duration of illness for < 3 months, followed by 27% for > 6 months and 17% 
presented with in 3 to 6 months.  In contrast, about 45% female subjects had the 
illness for < 3 months, 30% for 3 to 6 months and 25% for > 6 months before they 
sought treatment. The distribution of cases in those with symptoms less than 3 or 
more than 3 months was almost similar irrespective of gender. The details are 
provided in pictorial manner in figure 2. 
 
 The distribution of subjects according to clinical symptoms and gender is 
furnished in table 5 given below. 
 
TABLE – 5    CLINICAL SYMPTOMS AND GENDER  
 
MALE FEMALE  TOTAL 
SYMPTOMS 
No. % No.  % No.  % 
Cough with 
sputum 59(62) 84 20(17) 100 79 88 
Fever  40(46) 57 18(12) 90 58 64 
Hemoptysis  18(17) 25 3(4) 15 21 23 
Breathlessness  60(58) 85 13(15) 65 73 81 
Chest Pain  17(16) 24 3(4) 15 20 22 
Fatigue  24(21) 34 3(6) 15 27 30 
Weight Loss 36(37) 51 11(10) 55 47 52 
Anorexia  32(29) 45 5(8) 25 38 42 
 
 Numbers does not tally with total due to more than one symptom. Figures in 
brackets indicate expected values. 
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In this study, cough was the most common symptom observed in females 
(100%) whereas breathlessness was the commonest symptom in males (85%). In 
males the next common symptom was cough with sputum (84%), followed by 
fever (57%) whereas females presented more commonly with fever and 
breathlessness. Almost more than half of the study subjects complained of weight 
loss. 
The difference between the observed and expected values was not 
significant and hence clinical symptoms are independent of each other. Also the 
calculated probability value of chi-square was much less than the observed value 
of the chi-square at 5% level of significance with which it could be concluded that 
clinical symptoms among the subjects were independent of gender. The details are 
provided in figure 3.  
 
The smoking status of the study population is given in table 6. 
TABLE – 6  SMOKING STATUS OF THE STUDY SUBJECTS  
 
SMOKING STATUS NO. OF CASES PERCENTAGE 
Current Smokers 37 41 
Ex-Smokers 25 28 
Non-Smokers 28 31 
 
 
In this study population all the female subjects were non-smokers as smoking 
tobacco is considered a taboo in this part of the country. Among the males 40% 
were current smokers, 28% were Ex-smokers and 31% were non smokers. The 
details are shown in figure 4. 
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These elderly patients have one or more co morbid illness. The distribution of 
cases in relation to co morbid illness is given below in table 7. 
In this study population, diabetes was the most commonly observed co 
morbid illness affecting about 21% of the study population. Hypertension was 
found in 13% of patients followed by chronic obstructive pulmonary disease in 9% 
and ischemic heart disease in 6% of study subjects. Other co morbid illnesses were 
found in 23% of the population. No subject presented with malignancy. The 
details are depicted in figure 5. 
TABLE – 7   COMORBID ILLNESSESS AMONG  THE STUDY SUBJECTS 
 
COMORBID ILLNESS NO. OF CASES PERCENTAGE 
Diabetes 19 21 
Hypertension 12 13 
Ischemic Heart Disease  5 6 
Chronic obstructive 
pulmonary disease  8 9 
Malignancy 0 0 
Others 21 23 
  
Details of anemia, clubbing and lymphadenopathy observed in the study 
population are provided in the table 8 given below. 
TABLE – 8 GENERAL EXAMINATION FINDINGS IN STUDY SUBJECTS 
 
GENERAL EXAMINATION 
FINDINGS  
NO. OF CASES PERCENTAGE 
Anemia  67 74 
Clubbing  44 49 
Lymphadenopathy  4 5 
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Anemia is the most common finding present in about 74% cases followed 
by clubbing in 49% of subjects. Only 5% of the study subjects presented with 
Lymphadenopathy. Details are provided in figure 6. 
 The biochemical and hematological profile in the study subjects is provided in 
table 9 given below. 
TABLE – 9 BIOCHEMICAL & HEMATOLOGICAL PROFILE  IN STUDY                            
SUBJECTS 
 
CATEGORY RANGE  MEAN 
Hemoglobin (gm %) 6 – 11.6 8.9 ± 0.54 
Total count (cells / cu mm) 5500 – 12500 9088 ± 272 
Polymorphs (%) 59 – 83 72 ± 0.95 
Lymphocytes (%)  15 – 35 25 ± 2 
Eosinophils (%) 0 – 6 2 
Monocytes (%) 0 – 2  - 
Blood Sugar (mg %) 55 – 372 121.7 ± 17.4 
Blood Urea (mg %) 17 – 92 33.8 ± 4.1 
Serum Creatinine   0.5 – 3.3      0.93 ± 0.78 
 
The body mass index of the study subject vary from 12.7 to 29 and the mean ± SD 
was  17.4 ± 1.3. 
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RADIOLOGICAL PROFILE OF STUDY SUBJECTS 
Majority of the subjects (53%) had involvement of both lungs followed by 
26.6% with involvement of the right lung and only about 3.33% had involvement 
of the left lung. The details are furnished in 10provided below as well as in figure 
7 A. 
TABLE – 10  LUNG INVOLVEMENT AMONG STUDY SUBJECTS 
 
X-RAY CHEST  No. OF SUBJECTS AFFECTED  % 
Right Lung  24 26.6 
Left Lung 3 3.33 
Both Lungs  48 53 
 
Infiltration was a common observation in the x-ray chest in 45.5% of the 
subjects while cavitations were found only in 2.22% of subjects. In 34% of 
subjects both cavitations and infiltration was found. The details are furnished in 
table 11 A given below as well as in figure 7 B.    
TABLE – 11A  PATTERN OF LESIONS IN THE LUNG AMONG THE 
STUDY SUBJECTS  
 
X-RAY CHEST  No. OF SUBJECTS AFFECTED  % 
Cavitations  2 2.22 
Infiltration  41 45.5 
Both  31 34 
Pleural Effusion  12 13.33 
Pneumothorax  5 5.55 
Miliary Tuberculosis  4 4.44 
 
Involvement of upper and lower zone was found to be equally distributed in 
46% of the study subjects where as middle zone involvement was seen in 39% of 
the subjects.34% of the subjects all the zones involved. The details are furnished 
in table 11 B.    
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TABLE – 11B  INVOLVEMENT OF ZONES OF LUNG IN STUDY 
SUBJECTS  
X-RAY CHEST  No. OF SUBJECTS AFFECTED  % 
      Upper zone               41                 46 
      Middle zone               35                 39 
      Lower zone               41                 46 
     All zones               31                 34 
 
The following table 12 gives the distribution of radiological findings according to 
gender in the study population.  
TABLE – 12  RADIOLOGICAL FINDINGS ACCORDING TO GENDER IN 
THE STUDY POPULATION  
 
RADIOLOGICAL FINDINGS 
SEX 
CAVITATIONS INFILTRATION UPPER 
ZONE 
LOWER 
ZONE 
Male  25
 
52 47 42 
Female  7
 
16 14 7 
 
In assessing the radiological findings in the x-ray chest of the study 
subjects, it was seen that in males 25 of them had cavitations, 52 had infiltrations 
47 had upper zone involvement and 42 had lower zone involvement. Similar 
observation was seen among females as 7 of them had cavitations, 16 had 
infiltration, 14 had upper zone involvement and 7 had lower zone involvement. 
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As the observed and expected values are almost equal, in both sexes, it is 
clear that cavitation ( p = 0.99), infiltration(p = 0.6) and involvement of zones of 
the lung were independent of gender. 
 
The table 13 gives the radiological presentation of tuberculosis in elderly diabetic 
patients. 
 
TABLE – 13 : THE RADIOLOGICAL PRESENTATION IN ELDERLY 
TUBERCULOSIS PATIENTS WITH DIABETIC STATUS. 
 
                               LUNG INVOLVEMENT STATUS OF 
DIABETES Infiltration Cavitation Upper Zone 
Middle 
Zone 
Lower 
Zone 
Diabetic 9 8 8 21 18 
Non-
Diabetic 59 24 23 37 31 
 
Among the diabetic patients in the study population 9 presented with 
infiltration and 8 had cavitations in the lung which was evident from the x-ray 
chest. The middle zone involvement was found in 21 subjects, closely followed by 
lower zone involvement (18 subjects) while the upper zone is less affected among 
diabetics. (8 subjects).Among the non-diabetic subjects infiltration was seen in 59 
subjects, cavitations in 24 subjects, upper zone involvement in 23 subjects, middle 
zone involvement in 37 subjects and lower zone involvement in 31 subjects. 
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In the study population, it was observed that 9 diabetic patients had 
infiltration of the lung while 59 non diabetic subjects had infiltration. The details 
are furnished in table 13A given below.  
TABLE – 13A INFLUENCE OF DIABETES ON THE PRESENCE OF 
INFILTRATION IN THE LUNG.  
 
STATUS OF 
DIABETES INFILTRATION  NO INFILTRATON  TOTAL  
 Diabetic  9(14) 10(5) 19 
Non Diabetic  59(54) 12(17) 71 
Total  68 22 90 
The numbers in the bracket indicates the expected value.  
Using Chi-Square test, we observed that the evaluated chi-square probability value 
is deviated far away from the chi-square table value. So, we conclude that diabetes 
significantly influences the presence of infiltration of the lung. (p = 0.0035)  
 
Among the 32 subjects with cavitations in the lung 8 of them had diabetes while 
24 subjects were non diabetic. The details are furnished below in table 13 B. 
TABLE – 13B INFLUENCE OF DIABETES ON THE PRESENCE OF 
CAVITATION IN THE LUNG.  
 
STATUS OF 
DIABETES CAVITATION NO CAVITATION TOTAL 
 Diabetic  8(7) 11(12) 19 
Non Diabetic  24(25) 47(46) 71 
Total  32 58 90 
 
 The numbers in the bracket indicates the expected value.  
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The observed and expected values almost coincide with each other and 
hence the difference is not significant at 5% level of significance. Thus it can be 
concluded that cavitations in the lung was independent of diabetic status               
(p = 0.40).  
In this study population 18 diabetic subjects had lower zone involvement 
while 31 non diabetic had involvement of the lower zone. The details are furnished 
below. 
TABLE – 13C : INVOLVEMENT OF THE LOWER ZONE OF THE 
LUNG: DIABETES Vs NON DIABETES 
 
STATUS OF 
DIABETES 
LOWER ZONE 
INVOLVEMENT 
LOWER ZONE 
NON 
INVOLVEMENT 
TOTAL 
 Diabetic  18(10) 1(9) 19 
Non Diabetic  31(39) 40(32) 71 
Total  49 41 90 
 
 The numbers in the bracket indicates the expected values. It was observed 
that the probability value of the calculated chi-square value deviated far away 
from the table value of the chi-square. Hence, we conclude that diabetes influences 
the involvement of the lower zone of the lungs in the study population (p = 0.001).  
 
Smoking status and clinical symptoms as well as radiological presentation is 
furnished in table 14 below. 
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TABLE – 14 : INFLUENCE OF SMOKING ON THE CLINCIAL 
SYMPTOMS AND THE RADIOLOGICAL PRESENTATION IN THE  
STUDY SUBJECTS 
 
CLINICAL SYMPTOMS RADIOLOGICAL PRESENTATION 
STATUS 
OF  
SMOKING BREATH-LESSNESS COUGH 
HEMOP-
TYSIS 
INFIL-
TRATION 
CAVI-
TATION  
UPPER 
ZONE 
INVOL-
VEMENT 
LOWER 
ZONE 
INVOL-
VEMENT 
SMOKERS 54 60 19 46 18 50 36 
NON-
SMOKERS 15 21 3 20 12 15 13 
 
Among the subjects with the habit of smoking 54 presented with 
breathlessness, 60 with cough and 19 with hemoptysis. The radiological findings 
in x-ray chest revealed that 46 of them had infiltration, 18 had cavitations, 50 had 
upper zone involvement and 36 had lower zone involvement. Among the non-
smoking subjects 15 of them had breathlessness, 21 had cough, 3 had hemoptysis, 
20 presented with infiltration,12 with cavtation,15 with upper zone and 13 with 
lower zone involvement of the lung. 
In this study 54 subjects who had smoking habit presented with 
breathlessness while 15 non smoking subjects had breathlessness. The details are 
furnished below. 
TABLE – 14A  : SMOKING AND BREATHLESSNESS IN STUDY 
SUBJECTS 
 
STATUS OF 
SMOKING BREATHLESSNESS 
NO 
BREATHLESNESS TOTAL  
Smoker 54(48) 8(14) 62 
Non Smoker 15(21) 13(7) 28 
Total  69 21 90 
The numbers in the bracket indicates the expected values.  
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Using chi-square test, the significance of difference between smoking and 
breathlessness was calculated. It was inferred that smoking influenced 
breathlessness significantly (p = 0.001).  
In this study 19 smokers had hemoptysis while only 3 subjects with no 
smoking habit had hemoptysis. 
TABLE – 14 B   SMOKING AND HEMOPTYSIS IN STUDY SUBJECTS 
STATUS OF 
SMOKING HEMOPTYSIS NO HEMOPTYSIS  TOTAL  
Smoker 19(15) 43(47) 62 
Non Smoker 3(7) 25(21) 28 
Total  22 68 90 
The numbers in the bracket indicates the expected values. 
However, the difference between the expected and observed values was not 
significant at 2% level of significance using chi-square test. Thus it can be 
concluded that hemoptysis was independent of smoking status. 
In this study about 46 subjects with the habit of smoking had infiltration of 
the lung while 20 subjects with no smoking habit had infiltration (p = 0.225).  
TABLE – 14 C : SMOKING AND  INFILTRATION OF THE LUNG IN 
STUDY SUBJECTS 
 
STATUS OF 
SMOKING INFILTRATION  NO INFILTRATON  TOTAL  
Smoker 46(45) 16(17) 62 
Non Smoker 20(21) 8(7) 28 
Total  66 24 90 
The numbers in the bracket indicates the expected values.  
In this study about 18 smokers had cavitations and 12 non smokers had 
cavitations in the lungs (p = 0.15). The details are furnished below in table 14 D. 
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TABLE – 14D   : SMOKING AND  CAVITATION OF THE LUNG IN 
STUDY SUBJECTS 
 
STATUS OF 
SMOKING CAVITATION NO CAVITATION  TOTAL  
Smoker 18(21) 44(41) 62 
Non Smoker 12(9) 16(19) 28 
Total  30 60 90 
The numbers in the bracket indicates the expected values. 
Using chi-square test, it was found that smoking has no influence on the 
presence of infiltrations and cavitations in the lung .  
In this study about 50 subjects with the habit of smoking had upper zone 
involvement while 15 subjects with no smoking habit had upper zone involvement 
of the lung. 
TABLE – 14E   : SMOKING AND THE INVOLVEMENT OF THE UPPER 
ZONE OF THE LUNG   
 
STATUS OF 
SMOKING 
INVOLVEMENT 
OF UPPER 
ZONE 
NON 
INVOLVEMENT 
OF UPPER ZONE  
TOTAL  
Smoker 50(45) 12(17) 62 
Non Smoker 15(20) 13(8) 28 
Total  65 25 90 
The numbers in the bracket indicates the expected values. 
 It was observed that smoking influences the involvement of the upper zone 
of the lungs among the study subjects in contrast to the involvement of the lower 
zone in diabetic patients in the study population.  
      Sputum positivity was observed in 47 subjects out of 90 elderly 
tuberculosis patients studied. 
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DISCUSSION 
 
 In most Gerontological literature people aged above 60 years are 
considered as old and constitutes elderly segment of the population.   The Indian 
aged population is currently the second largest in the World.  The absolute number 
of the over 60 population in India will increase from 76 million in 2001 to 137 
million by 2021. From 5.4% in 1951, the proportion of 60+ people grew to 6.4% 
in 1981 and it was close to 8.1% in 2001.The decadal percent growth in the elderly 
for the population for the period 1997 – 2001 would be close to 40, more than 
double the rate of increase for the general population (Prakash et al 1999). 
 This study was intended to find out the Socio demographic patterns, signs, 
symptoms and diagnostic aspects of tuberculosis in the elderly.   90 people who 
satisfied the inclusion criteria were subjected for study.  After getting history, all 
the patients were clinically examined and relevant investigations were carried out. 
 The mean age of the study population was 63.8.  It was 63.6 in males and 
64.1 in females respectively. A study from Hong Kong by Chan et al (1994) 
showed mean age was 73.9 years. Another study by Rizvi. et al (2003) from 
Pakistan had a mean age of 65.92 years where it was 71 years by Van den Brande 
et al. (1991) from USA. All these indicate the mean age is close to the longevity of 
the respective country. 
        In the present study the male, to female ratio was 4.5 :1 in elderly. Analysis 
of sex ratio in WHO region for tuberculosis was found to be approximately 0.3 in 
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South East Asia (SEARO), approximately 0.5 in the Western Pacific region 
(WPRO) and approximately 1 in Sub Sahara Africa.  (Borgdorff et al 2000) 
TABLE 15  Comparison of  sex differences in the tuberculosis in WHO region 
Study population 0.22 
SEARO Region 0.3 
WPRO Region 0.5 
AFRO Region 1 
Chan et al (2002) 0.25 
  
According to Chan et al (2002) tuberculosis rate was higher in men than 
women of all age groups and the sex differences increase with age. In those aged 
60-79 years, men had four times the rate of tuberculosis than women. The high 
rate of tuberculosis observed in women of reproductive age in the past had been 
attributed to the stress of pregnancy.  However, studies by Snider et al (1984) and 
Hamedah et al (1992) failed to support such hypothesis. There was also high 
degree of unreporting by females in our set up.  
         Immunologically when compared with males, women were said to have 
high proportion of CD4 Lymphocytes  (Prince et al 1985).Older men tended to 
have high rate of progression to disease. Alcohol abuse and smoking which 
depresses immune function have been blamed for disease progression or 
reactivation in men (Brown et al 1961). Chan et al also demonstrated that women 
were more adherent to treatment when compared with men. The over all rate of 
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cure and treatment completion at 12 months was 80.4% and it was higher in 
women than men especially for those with extra pulmonary disease, when 
treatment was usually more prolonged. 
In this study greater than 50% of patients present within 3 months after the 
beginning of symptoms. Also, tuberculosis was not suspected initially in 13 out of 
31 (42%) patients with active disease. Eleven of the thirteen patients were older 
than 65 years. These patients also had longer hospitalization and higher mortality 
than did those in whom the diagnosis was suspected early. Arora and Bedi et al 
showed only 40% of the elderly tuberculosis patients were aware that their 
symptom could be due to tuberculosis. The elderly are more likely to have chronic 
cardiac and/or pulmonary disease, malignancy and immunosuppression than 
younger patients. Therefore symptoms may be over looked, or attributed to some 
other ailment common among the elderly. Although the classic symptoms of fever, 
weight loss, chronic cough and hemoptysis were  present   in   the   elderly they 
were often attributed to chronic bronchitis or malignancy .Therefore, tuberculosis 
a treatable condition was less considered. Non specific symptoms of anorexia and 
weight loss were more common in the older patients. The diagnosis was frequently 
missed in the elderly because the patient also suffers from a more acute condition 
which preoccupied the attention of the doctor.  
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TABLE 16  Frequency of symptoms in Elderly Tuberculosis  in various studies   
 
Clinical 
symptoms Present study 
Chan  et al 
(1994) 
Korzeniewska et 
al (2000) 
Breathlessness  81 % 18.5 % 21 % 
Fever 64 % 13.5 % 19.7 % 
Cough 88 % 4.3 % 40.7 % 
Chest pain  22 % 4.9 % 13.15 % 
Weight loss 52 % 7.4 % 31 % 
Anorexia  42 % 7.4 % 17 % 
Hemoptysis 23 % 7.4 % 5.2 % 
 
 
 In our present study, the most common presenting complaint was cough 
(88%) which was also the commonest symptom in the series of Chan et al (1994). 
Korzeniewska et al (2000) and Arora et al (1989) noted breathlessness was the 
main symptom (Table 16). According to Ritasood (1993) presentation of patients 
with fever and hemoptysis was significantly low.  It was 64% and 23% 
respectively in our population. Brande et al (1990) stated that prevalence of cough, 
dyspnoea, anorexia & weight loss was higher in tuberculosis the elderly. 
 In our study population Diabetes was the commonest co morbid illness 
(21%).   Next was hypertension which was present in 13% of cases. Comparative 
analysis of co morbid illness among the elderly tuberculosis is furnished in         
table 17. 
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TABLE 17 Comorbid illness in various studies in Tuberculosis in the elderly 
Comorbid illness  Present study Vats   et al (2003) 
Chan et  al 
(1994) 
Diabetes  21 % 14 % 7.5% 
Hypertension  13 % 12 % - 
Ischaemic heart 
disease   6 % 0% 7.5% 
COPD / Asthma   9 % 21% 15% 
Malignancy  01% 5% 3.2% 
Cerebro vascular  
accident  -- -- 8.6% 
Cirrhosis of liver  -- -- 2.15% 
Renal failure  -- -- 1% 
 
TABLE 18  Prevalence of Diabetes in tuberculosis among the elderly 
 
Present study 21% 
Claw et al (1995) 14.3% 
Vats et al (2003) 14% 
Chan et al (1994) 7.5% 
Villarino et al (2001)  22% 
Yamaguchi et al (2001) 12.7% 
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TABLE 19 Incidence  of Pulmonary tuberculosis in Diabetic population 
 
Windke et al  (1883) 50% 
Root  et  al (1984) 2.8% 
Philadelphia Survey (1952) 8.4% 
Korean study 8.3% 
 
TABLE 20  Prevalence of Diabetes in Pulmonary tuberculosis population 
 
Nicholas et al (1957) 5% 
Muticentric study in India (1957) 9.7% 
TANZANIA study 9% 
OG TT Surrey (1990) 4% 
Japan study (1987) 13.2% 
 
      Diabetes mellitus is recognized as an independent risk factor for developing 
lower respiratory tact infections.  Tuberculosis occurs with increase frequency in 
diabetes and causes a significant mortality (Konda et al 1996).  Root (1994) 
postulated that the association between two diseases was one sided i.e. diabetic 
patients tended to contract tuberculosis but the reverse was rare. 
 The Philadelphia population survey revealed that 8.4% of 3,106 diabetics 
had pulmonary tuberculosis as compared to 4.3% of the 71,767 presumably 
healthy industrial workers.  Tuberculosis was present in 17% of the diabetics who 
had the disease for more than 10 years compared to 5% in the diabetics with less 
than 10 years of the disease.   Diabetes mellitus was present in 8.3% of the cases 
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of reactivation tuberculosis in New York City. (Basach et al 1928). The prevalence 
of diabetes in pulmonary tuberculosis and pulmonary tuberculosis among diabetes 
are provided in table 18 & 19 and table 20 respectively. 
A probable cause of increased incidence of pulmonary tuberculosis in 
diabetics could be defect in host defense mechanism and immune cell function.    
The immune derangements predominantly involve the cell mediator arm of the 
immune system (Mamahon et al.1995). The degree of hyperglycemia had been 
found to have a distinct influence on the microbiological function of macrophages, 
with even brief exposure to blood sugar level of 200 mg %. This was borne out   
by observation  that in poorly controlled diabetic, with high levels of glycosylated 
hemoglobin, tuberculosis follows a more destructive course and associated with 
higher mortality. (Noziet et al 1995).  Infection with tubercle bacilli leads to 
further alteration of cytokines, monocytes, macrophages and CD 4 / CD 8  T cell 
population.  The balance of the T-lymphocyte subsets CD 4 & CD8 plays a central 
role in the modulation of host defenses against mycobacteria and has a profound 
influence on the rate of regression of active Pulmonary Tuberculosis (Wang et al 
1995). 
TABLE 21  Frequency of smokers in Tuberculosis in the elderly patients 
 
Present study (Madurai – Tamilnadu) 69% 
Chennai survey (1995 – 97) (Urban)(Northern Tamilnadu) 72.2% 
Villupuram survey (1997-98) (Rural)(Tamilnadu) 58.62% 
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 From this table, it became clear there is a high prevalence of smokers in 
elderly tuberculosis population. The mechanism for the development of TB among 
smokers  are furnished below. 
 The prevalence of tuberculosis increases with the number of cigarettes 
smoked.  In smokers airway was compromised.  Smoke induces oxidative damage 
along with recruitment of inflammatory cells resulting in damage to the respiratory 
passages. Alveoli and airway secretions are increased through goblet cell 
metaplasia. Peribronchial fibrosis leads to air flow obstruction causing irreversible 
anatomical changes in the lungs. Lung defence mechanism is further affected by 
declining mucocilliary clearance. Now the lung becomes the fertile ground for 
Mycobacterium tuberculosis (Stephen et al 1998).   Smokers usually suffer from 
chronic bronchitis with constant coughing which leads to increase chances of 
droplet infection. Besides smoke itself may act as a carrier.   Smoking has become 
a risk factor for development of active disease in family contacts of pulmonary 
tuberculosis cases with a close relationship to the number of cigarettes smoked per 
day (Al Caide et al 1996).    
The mean body mass index in our population was 17.4.  Chan et al (1994) 
showed that the body weight of the elderly patients was significantly lower than 
that of the young patients (44.2 + 14.6 Kg. Vs 48.3 + 8.84 Kg, p < 0.05). Umeki et 
al (1989) also made out that weight loss was significantly higher in elderly 
tuberculosis patients (43%).  
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The reasons for the weight loss in elderly tuberculosis may be 
a) Coexisting medical illness 
b) Malnutrition 
c) Cytokines (TNFα , IL-2, 1 IFN γ ) Produced by Fibroblasts, macrophages 
also contributes to cachexia.  (Ashrun et al 1999) and 
d) Smoking and alcohol abuse 
            Anemia was diagnosed in about 75% of study population.The mean 
Hemoglobin observed in our study was 8.1 mg .Chan et. al (1994)  observed that 
52% of elderly tuberculosis patients were anemic. 
The causes for anemia in tuberculosis in the elderly are 
a) Appetite loss 
b) Hemoptysis 
c) Anemia of chronic disease 
d) Disseminated tuberculosis which have depressive  effect on bone marrow 
e) Co morbid  medical illness and 
f) Malnutrition 
In this study 5% of patients had military tuberculosis. According to 
Korzeniewska et al (2000) 6.7% of elderly tuberculosis had miliary pattern 
whereas it was 0.7 % in the younger patients. As against this Brande et al (1989) 
showed that miliary pattern in 2 out of 55 patients. “Miliary tuberculosis seems 
common in the elderly, this presentation occurring in up to 1 in 20 cases”. This 
statement was made out by John Pathy in Geriatric Medicine (3rd edition). 
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 In this study infiltrative pattern was observed in 46% whereas cavitation 
was made out in 2.22% of the chest x-rays. Rizvi et al (2003) also made out 
extensive infiltrative lesions in their study of “Clinical presentation of pulmonary 
tuberculosis in association with age” when compared with younger patients. 
Perez-Guzman et al (2000) also noted declining frequency of cavitations with age. 
Chan et al (1995) stated that elderly tuberculosis patients had extensive infiltrative 
lesions involving both the lungs.  
 Lower and upper zone involvement was found to be equally distributed 
(46%) among the study subjects. This result was similar to the study by Perez- 
Guzman et al (2000).As age advances there will be reduced perfusion and 
increased alveolar ventilation. This results in ventilation perfusion mismatch. 
These changes were more observed in the lower lung fields. They have higher 
alveolar oxygen concentration and ventilation perfusion ratio. Therefore age 
induced changes favors multiplication of tubercle bacilli in lower lung fields. 
Rizvi et al (2003) and Umeki et al (1989) also made out lower lung field lesions in 
elderly patients when compared with young. In contrast to the above Brande et al 
(1989) concluded that the radiological manifestations of pulmonary tuberculosis in 
elderly patients do not differ in frequency or distribution from those seen in the 
young adults. 
    When the radiological manifestations of elderly tuberculosis in diabetic 
population were studied it was found that there was a significant involvement of 
lower zone and more infiltrative pattern when compared with non diabetic 
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population. Perez – Guzman et al (2000) also demonstrated similar type of 
findings. Marias (1980) observed lower lung field tuberculosis in 29% patient with 
diabetes as compared to 4.5% in non diabetic population.Cavitation was less 
common because diabetes mellitus itself is an immunodeficiency state which 
decreases cell mediated immunity and it results in less tissue destruction. 
          In this study, infiltration and cavitation was observed in 46 and 18 patients 
respectively among smokers. Upper zone and lower zone was almost equally 
involved.Cavitation and infiltration was noted in 35% and 70% in males where as 
it was 35% and 80% in females respectively. It was found statistically that 
smoking and gender has no influence on the radiological patterns in tuberculosis in 
the elderly. 
 In the study sputum was positive in 54% of elderly tuberculosis patients. 
Gaur et al (2004) had shown previously bacteriologically positive cases were more 
in younger people when compared with elderly people (59.6% Vs 63.8%). In 
contrast the bacteriologically confirmed TB cases increased with age from 59.8% 
in those less than 20 years to 76.2% in those greater than 80 years in a study from 
Hong Kong by Chan-Yeung et al (2002). 
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AREAS OF RESEARCH IN ELDERLY PULMONARY TUBERCULOSIS 
1. Response to DOTS schedule. 
2. Drug toxicity. 
3. Pharmacodynamics status. 
4. Compliance pattern. 
5. Microbiological and genetic studies of isolate of pulmonary 
tuberculosis. 
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CONCLUSIONS 
 
1. Elderly men  more likely to suffer from tuberculosis when compared with 
elderly women (M:F = 4.5:1). 
2. Irrespective of gender, elderly patients were diagnosed to have tuberculosis 
only 3 months after the onset of symptoms. 
3. The commonest presenting symptoms were cough and breathlessness. 
4. About 70% of elderly male tuberculosis patients were smokers. (All 
females were non smokers). 
5. Body Mass Index was lower than the Indian standards. 
6. Anemia was observed in about three fourths of the study population. 
7. Involvement of both lungs (53%) was more common than the isolated 
involvement of the right (26%) or left lung (3.3%). 
8. Infiltrative pattern was observed more than the cavitatory pattern on the 
chest x-ray of the study population. 5% of the study population has miliary 
tuberculosis. 
9. Radiological findings were not influenced by smoking or gender. 
10.  Diabetes mellitus was observed in about 21% of the study population. 
These patients had significantly lower lobe and infiltrative pattern of    
involvement  
11. Sputum positivity was observed in 53% of elderly subjects. 
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SUMMARY 
      Studies on pulmonary tuberculosis in elderly are gaining importance 
globally, in view of increase in the longevity and their immunological 
susceptibility to tuberculosis. The present report deals with pulmonary 
tuberculosis in elderly with special emphasis on the socio-demographic, clinical 
and laboratory aspects. A total of ninety elderly (Males = 70 & Females = 20, 
mean age 63.7 years) subjects  who satisfied a rigid set of inclusion and exclusion 
criteria were analyzed with respect to the objectives after obtaining institutional 
ethical clearance and informed consent. Data were analyzed statistically. 
It was observed from this study that elderly men suffered from tuberculosis 
more than the elderly women and about 90% of them were smokers. Most of the 
subjects were diagnosed to have tuberculosis only three months after the onset of 
illness with the commonest symptoms, being cough and breathlessness. About 
75% of the study population had anemia with body mass index lower than the 
Indian standards.  
Involvement of both lungs was common with infiltrative pattern more 
frequently observed than cavitatory pattern in the X-ray chest. 5% of the study 
population had military tuberculosis. 21% of the study population had diabetes 
mellitus where these patients had significantly involvement of lower lobe of lung 
and infiltrative pattern. Radiological findings were not influenced by gender and 
smoking. Sputum positive status was observed in  53 % of cases.  
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 In view of the increased prevalence of pulmonary tuberculosis in the elderly 
and multiple reasons for the susceptibility, clinicians should suspect pulmonary 
tuberculosis in the elderly with cough and breathlessness and treat them 
accordingly after identifying associated co morbid status. 
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Appendix II 
 
PROFORMA  
 
A STUDY ON ELDERLY TUBERCULOSIS: SOCIAL, CLINICAL, 
RADIOLOGICAL & MICROBIOLOGICAL ASPECTS 
 
 
 
Name :                                                     Age:                               Sex: 
Address:                                                   IP No:                            Ward / Unit: 
Chief Complaints:  
History of Present Illness:  Duration of Illness: 
1) Cough with Expectoration                                                a) less than 3 months 
2) Breathlessness                                                                   b) 3 to 6 months 
3) Fever                                                                                  c) more than 6 months 
4) Chest Pain 
5) Hemoptysis 
6) Anorexia 
7) Weight loss 
8) Fatigue 
9) Others 
History of Past Illness: 
1) Diabetes mellitus 
2) Hypertension 
3) Chronic Obstructive Pulmonary Diseases 
4) Asthma 
5) Ischemic Heart Diseases 
6) Malignancy 
7) Others 
Personal History: 
   1)  A) Smoker            B) Non- Smoker             C) Ex – Smoker 
    2)  A) Alcoholic        B) Non – Alcoholic         C) Ex – Alcoholic 
 ix
Contact History: 
 
Treatment History: 
 
General Examination: 
a) Anemia              b) Clubbing                 c) Lymphadenopathy 
Vitals: 
   Pulse Rate: 
   Respiratory Rate: 
   Blood Pressure: 
   Height: 
   Weight: 
Body Mass Index: 
 
System Examination: 
Cardiovascular System: 
 
Respiratory System: 
 
Abdomen: 
 
Central Nervous System: 
 
Investigations: 
1) Hemogram 
a) Total Count    
b) Differential Count  
c) Hemoglobin 
d) Erythrocyte Sedimentation Rate 
2) Blood Urea 
3) Blood Sugar 
 x
4) Serum Creatinine 
      5)   X-Ray Chest: 
                 I)  a) Right Lung           b) Left Lung            c) Both 
                 II)  a) Cavitation            b) Infiltration          c)  Both         d) Miliary Pattern 
                 III)  a) Upper zone     b) Middle Zone    c) Lower zone     d) All Zones 
                 IV)  Pleural Effusion 
                 V)    Pneumothorax 
                 VI)   Pyothorax 
       6)   Sputum AFB 
    a)   1+               b)   2+           c)   3+ 
        
Category of ATT Started: 
a) Category  I 
b) Category  II 
c)  Category  III 
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Key To Master Chart 
Age:  1)    60-70 years     2)    >  70 years 
Sex:    1)    Male                  2)    Female 
Duration Of Illness:  1)  < 3 months    2)  3 – 6 months      3) > 6 months 
Symptoms:     1) Present          2) Absent 
Co morbid  Illness:    1) Present          2) Absent 
Smoking / Alcoholism :  1)  Current Smoker / Alcoholic 
                                        2)  Non- Smoker / Alcoholic 
                                        3)  Ex- Smoker / Alcoholic 
X-Ray Chest:    1) Present          2) Absent 
Sputum AFB:    1) Present          2) Absent 
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21 1 1 2 4 2 1 1 1 1 2 2 1 1 1 1 2 2 2 2 2 PT 
22 1 1 2 6 3 1 1 1 1 2 1 2 2 1 1 2 2 2 2 2 PT 
23 1 1 2 7 1 1 2 2 1 2 1 2 2 1 1 2 2 2 2 2 2 
24 1 1 2 6 3 1 2 1 1 1 2 2 2 1 1 2 2 2 2 2 PT 
25 2 1 2 4 1 1 2 2 1 1 2 2 2 2 3 2 1 2 2 2 2 
26 1 1 2 0 1 1 1 2 1 2 2 1 2 3 3 2 2 2 2 2 2 
27 1 1 2 5 1 1 1 2 1 2 2 2 2 3 3 1 2 2 2 2 2 
28 1 1 2 6 1 1 1 2 1 2 2 1 2 1 3 2 2 2 2 2 2 
29 2 1 2 2 1 1 1 2 1 2 2 2 2 3 3 2 1 1 2 2 2 
30 2 1 2 4 1 2 2 2 1 1 2 2 2 3 3 1 2 2 2 2 2 
31 1 2 2 17 1 1 1 2 2 2 2 2 3 3 1 2 2 2 2 2 2 
32 1 1 2 5 1 1 1 2 2 2 1 1 1 1 2 2 2 2 2 2 2 
33 1 2 2 3 2 1 1 2 1 2 1 1 2 2 2 2 2 2 2 2 PT 
34 1 2 2 6 2 1 1 2 1 2 2 2 2 2 1 1 1 2 2 2 2 
35 1 2 2 6 2 1 1 2 1 2 2 1 2 2 2 2 2 2 2 2 PT 
36 1 2 2 5 3 1 1 2 1 1 2 1 2 2 2 1 1 2 2 2  
37 1 2 2 8 3 1 1 1 1 2 2 1 2 2 2 2 2 2 2 2 2 
38 1 1 2 2 3 2 2 2 1 2 2 2 3 3 2 2 2 2 2 2 PT 
39 1 1 2 7 2 1 1 2 1 2 1 1 1 3 2 2 2 2 2 2 2 
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40 1 1 2 4 3 1 1 2 2 2 1 1 3 3 2 2 2 2 2 2 2 
41 1 2 1 8 2 1 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
42 1 2 2 4 1 1 1 1 1 2 2 2 2 2 1 2 2 2 2 2 2 
43 1 2 2 4 1 1 2 2 1 2 2 1 2 2 2 2 2 2 2 2 PT 
44 1 1 2 1 1 1 1 1 1 2 2 1 3 3 2 2 2 2 2 2 PT 
45 1 1 2 3 3 1 1 2 1 2 2 2 1 3 2 2 2 2 2 2 PT 
46 1 1 2 4 3 1 1 2 1 2 2 1 1 2 1 2 2 2  2 2 2 
47 1 2 2 2 2 1 1 2 1 2 2 1 2 2 2 2 2 2 2 2 2 
48 1 1 2 6 3 1 2 1 1 2 1 1 1 1 3 2 1 2 2 2 2 
49 2 1 1 3 1 1 2 2 1 2 1 2 2 3 3 2 2 2 2 2 PT 
50 1 2 2 1 3 1 1 1 1 2 2 1 1 3 3 2 1 1 2 2 CRF 
51 1 1 2 6 3 1 2 2 1 2 2 1 1 1 1 2 2 2 1 2 2 
52 1 1 1 4 3 1 2 2 1 2 1 1 1 1 1 2 2 2 1 2 2 
53 1 1 2 3 1 1 1 2 2 2 2 1 1 1 3 2 2 2 2 2 2 
54 2 1 2 1 3 1 2 2 1 2 2 1 1 2 3 2 2 2 1 2 2 
55 2 1 2 4 2 1 2 2 1 2 2 2 2 1 2 2 2 2 1 2 2 
56 1 1 2 5 3 1 1 2 1 2 2 1 1 1 1 2 2 2 2 2 2 
57 1 1 2 6 1 1 1 2 1 2 1 1 1 3 1 2 2 2 2 2 2 
58 1 1 2 0 2 1 2 2 1 2 2 2 2 2 3 2 2 2 2 2 1 
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59 1 2 2 8 2 1 1 2 1 1 1 2 2 3 3 2 2 2 2 2 2 
60 2 1 2 0 2 1 2 2 1 2 2 2 2 2 3 2 2 2 2 2 1 
61 1 1 2 7 3 1 2 2 1 1 2 1 1 2 2 2 2 2 1 2 PT 
62 1 1 2 5 1 2 2 2 1 2 2 1 1 1 1 2 2 2 2 2 PT 
63 1 1 2 2 1 1 1 2 2 2 2 2 2 3 3 1 2 2 2 2 2 
64 1 1 2 6 1 2 2 1 2 2 2 2 2 2 3 2 2 2 2 2 2 
65 1 1 2 3 1 2 2 2 1 1 2 2 2 1 1 2 1 2 1 2 2 
66 2 2 2 6 1 1 1 2 2 2 2 2 2 3 3 2 2 2 2 2 2 
67 1 1 2 6 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 PT 
68 1 1 2 6 1 1 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
69 1 1 2 0 1 2 1 2 1 2 1 1 1 3 2 1 2 2 2 2 2 
70 1 2 2 5 1 1 1 2 2 2 1 1 1 3 3 2 2 2 2 2 2 
71 1 1 2 4 1 1 1 2 2 1 2 2 2 3 3 1 2 2 2 2 2 
72 1 1 2 3 1 1 1 1 1 1 1 1 1 2 2 2 2 1 2 2 2 
73 2 1 2 11 2 1 1 1 1 2 2 2 2 1 2 2 2 2 2 2 2 
74 1 2 2 5 1 1 1 2 1 2 2 2 2 1 1 1 2 2 2 2 2 
75 2 1 2 3 2 1 2 2 1 2 2 1 1 3 3 1 2 2 2 2 2 
76 2 1 2 5 3 1 1 1 2 2 1 1 1 1 3 2 2 2 2 2 2 
77 1 1 2 4 1 1 2 2 1 2 1 1 1 1 1 2 2 2 2 2 2 
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78 1 2 2 2 3 1 1 1 1 2 2 1 1 1 1 2 2 2 2 2 2 
79 2 1 2 4 2 1 1 2 1 1 1 1 1 1 1 1 1 2 2 2 2 
80 1 1 2 6 3 1 1 2 1 1 1 1 1 1 1 2 2 2 2 2 2 
81 1 1 2 4 2 1 1 1 1 2 2 1 1 1 1 2 2 2 2 2 PT 
82 1 1 2 6 3 1 1 1 1 2 1 2 2 1 1 2 2 2 2 2 PT 
83 1 1 2 7 1 1 2 2 1 2 1 2 2 1 1 2 2 2 2 2 2 
84 1 1 2 6 3 1 2 1 1 1 2 2 2 1 1 2 2 2 2 2 PT 
85 2 1 2 4 1 1 2 2 1 1 2 2 2 2 3 2 1 2 2 2 2 
86 1 1 2 0 1 1 1 2 1 2 2 1 2 3 3 2 2 2 2 2 2 
87 1 1 2 5 1 1 1 2 1 2 2 2 2 3 3 1 2 2 2 2 2 
88 1 1 2 6 1 1 1 2 1 2 2 1 2 1 3 2 2 2 2 2 2 
89 2 1 2 2 1 1 1 2 1 2 2 2 2 3 3 2 1 1 2 2 2 
90 2 1 2 4 1 2 2 2 1 1 2 2 2 3 3 1 2 2 2 2 2 
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1 ATT 1 1 2 19.14 7 8400 72 26 2 0 105 26 0.9 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 II 
2 ATT 2 2 2 14.56 8 8200 64 28 6 2 114 60 1.3 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 II 
3 OHA 1 2 2 19.10 9.3 8600 76 22 2 0 310 31 1.2 1 2 2 2 2 2 2 2 1 2 2 1 2 2 2 I 
4 --- 2 1 2 18.70 10.2 9900 75 23 2 0 82 32 0.8 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 I 
5 ATT 1 2 2 16.79 10.40 7600 70 30 0 0 81 48 1.7 1 1 1 1 1 1 1 1 1 2 2 2 2 1 2 II 
6 --- 1 2 2 16.00 8.2 5500 68 30 2 0 88 44 1.2 1 2 2 1 1 1 1 2 2 2 2 2 1 2 2 I 
7 ATT 2 1 2 19.50 10.2 12500 82 16 2 0 116 41 1 1 1 1 2 1 2 1 2 1 2 2 2 2 1 2 II 
8 --- 2 1 2 18.00 11.0 7600 68 30 2 0 72 54 1.3 1 2 2 2 2 2 2 2 1 2 2 1 1 2 2 I 
9 OHA 1 2 2 29.00 7.80 7200 73 25 2 0 100 92 1.9 2 2 2 2 2 2 2 2 2 2 2 1 1 2 2 I 
10 --- 1 2 2 14.10 8.00 11000 76 22 2 0 100 22 0.8 1 1 1 1 1 1 1 1 1 2 2 2 1 2 2 I 
11 --- 2 2 2 17.90 11.00 10000 82 16 2 0 35 50 1.1 2 2 2 2 2 2 2 2 1 2 1 2 2 2 2 I 
12 ASA   B block 2 2 2 18.80 
10.8
0 11700 80 18 2 0 60 27 1.0 2 1 2 2 1 2 2 2 1 2 2 2 2 2 2 I 
13 --- 1 2 2 17.70 10.20 8800 76 22 2 0 105 17 0.6 1 1 1 2 1 2 1 1 1 2 2 2 2 2 2 I 
14 OHA 1 2 2 19.50 8.0 7500 75 25 1 0 365 22 0.9 1 1 1 2 1 2 1 1 1 2 1 2 2 2 2 I 
15 OHA 1 2 2 22.60 7.0 7500 69 30 1 0 214 33 0.8 1 1 1 1 1 1 1 2 1 2 2 2 2 1 2 I  
16 --- 1 2 2 17.50 8 7600 82 18 0 0 90 27 0.7 1 1 1 2 2 1 1 1 1 2 2 2 1 2 2 I 
17 --- 1 2 2 12.70 9.2 8900 66 32 2 0 90 56 1.5 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 I 
18 --- 2 1 2 17.0 9.6 8600 59 35 6 0 69 43 0.7 1 2 2 2 1 2 1 2 2 2 2 2 2 2 2 I 
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19 OHA 1 2 2 16.1 9.6 10500 71 26 3 0 310 22 0.9 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 I 
20 --- 1 2 2 21.0 8.8 10000 83 15 2 0 86 24 0.8 1 2 2 1 1 1 1 1 1 2 2 2 1 2 2 I 
21 ATT 2 2 2 22.0 11.6 7600 76 22 2 0 90 20 0.9 1 2 2 2 1 2 1 2 2 2 2 2 2 2 1 I 
22 ATT 1 1 2 19.1 10.6 11000 82 17 1 0 144 28 0.8 1 1 1 1 1 1 1 1 1 2 2 2 1 2 2 II 
23 --- 1 1 2 19.0 7.0 8600 66 32 2 0 93 28 0.8 1 1 1 2 1 2 1 1 1 2 2 2 1 2 2 I 
24 --- 1 1 2 18.0 8.2 9200 77 21 1 0 83 38 0.1 1 2 2 1 2 2 1 1 1 1 2 2 2 2 2 II 
25 --- 2 1 1 16.1 10 8500 60 38 2 0 120 75 1.3 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 III 
26 --- 1 1 2 16.4 9 9000 67 30 3 0 90 20 0.6 1 1 1 2 1 2 2 1 2 2 1 2 2 2 2 I 
27 OHA 2 1 2 19.5 9.6 10200 78 20 2 0 179 25 0.7 1 1 1 1 1 1 1 1 1 2 2 2 2 2 1 I 
28 --- 1 2 2 16.2 10.2 10500 80 17 2 0 90 20 0.7 1 1 1 2 1 2 1 1 1 2 2 2 2 2 2 I 
29 Anti.H7 1 1 1 21.2 8.4 8900 78 20 2 0 78 18 0.8 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 III 
30 OHA 2 1 2 21.0 11.2 9600 67 22 1 0 375 29 0.9 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 I 
31 OHA 1 2 2 17.7 10.6 9900 81 17 2 0 300 25 0.8 1 2 2 1 1 1 1 2 2 2 2 2 1 2 2 I 
32 --- 1 2 2 15.5 9.2 9600 69 30 1 0 75 30 1.9 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 III 
33 ATT 1 2 2 17.0 6.8 10500 85 13 2 0 137 18 0.9 1 2 1 1 1 1 1 2 2 2 2 2 2 1 2 II 
34 OHA 1 2 2 18.6 8.6 9600 70 28 2 0 261 31 0.8 1 1 1 1 1 1 1 2 2 2 2 2 2 1 2 I 
35 ATT 1 1 2 15.5 8.6 9000 73 27 0 0 76 32 0.8 1 1 1 1 1 1 2 1 1 2 2 2 1 2 2 II 
36 + 1 2 2 17.36 7.2 8800 61 37 2 0 84 36 0.7 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 III 
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37 + 1 2 2 14.5 8.0 8800 70 28 2 0 72 26 0.8 2 2 2 2 1 2 2 2 2 2 2 2 2 2 1 I 
38 ATT 1 1 2 13.20 7.0 9800 71 27 2 0 76 31 0.9 1 2 2 2 1 2 1 2 2 2 2 2 1 2 2 I 
39  1 1 2 15.00 8.2 9800 72 26 2 0 84 26 0.7 1 1 1 2 1 2 1 1 2 2 2 2 2 1 2 I 
40  1 1 2 14.5 9.6 9800 71 27 2 0 76 32 0.5 1 1 1 1 1 1 1 1 1 2 2 2 1 2 2 I 
41 + 1 1 2 12.0 6.0 10000 71 26 3 0 91 26 0.8 1 2 2 2 1 2 1 2 2 2 2 2 2 2 1 I 
42 + 1 1 2 16.0 7.0 8900 69 27 4 0 74 29 0.7 1 2 2 2 1 2 1 2 2 2 2 2 1 2 2 I 
43 + 1 1 2 17.0 7.6 7600 72 26 2 0 77 32 0.9 1 1 1 2 1 2 2 1 1 2 2 2 1 2 2 I 
44  1 1 2 18.5 8.6 9900 79 19 2 0 82 26 0.7 1 1 1 1 1 1 1 1 1 2 2 2 2 2 1 I 
45  1 1 2 16.0 7.2 9000 70 27 3 0 75 27 0.9 1 1 1 2 1 2 1 1 1 2 2 2 2 2 2 I 
46  1 2 2 13.2 7.2 8800 65 33 2 0 76 29 0.6 1 2 2 2 1 2 1 2 2 2 2 2 1 2 2 I 
47  1 2 2 20.4 8.6 8600 69 29 2 0 84 22 0.8 1 2 2 2 1 2 1 2 1 2 2 2 2 1 2 I 
48  1 1 2 19.2 9.2 9800 77 20 3 0 94 26 0.7 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 I 
49 ATT 2 1 2 16.8 11.2 8900 66 32 2 0 100 39 1.9 1 2 2 1 1 1 1 1 1 2 2 2 1 2 2 I 
50  1 2 2 17.3 8.3 8900 67 29 2 0 76 89 3.3 1 1 1 2 1 2 1 1 2 2 2 2 2 2 2 I 
51  1 1 2 13.2 7.2 8800 67 30 3 0 84 22 0.8 1 1 1 2 1 2 1 2 2 2 2 2 2 2 2 I 
52  1 1 2 11.9 7.6 8900 67 30 3 0 96 26 0.7 1 1 1 2 1 2 2 1 1 2 2 2 2 2 2 I 
53  1 1 2 17.6 8.4 7900 66 32 2 0 102 28 0.9 2 1  2 2 1 2 2 2 1 2 2 2 2 2 1 I 
54  1 1 2 17.6 8.6 8980 67 30 3 0 76 32 0.9 1 1 1 2 1 2 1 2 2 2 2 2 2 2 2 I 
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55  1 1 2 15.20 7.6 8900 70 30 3 0 96 28 1.1 1 2 2 2 1 2 1 2 2 2 2 2 2 2 2 I 
56  1 2 2 16.00 8.4 9200 70 28 2 0 100 32 1.2 1 1 1 1 1 1 1 1 1 2 2 2 2 1 2 I 
57  1 2 2 16.0 8.6 8600 63 33 4 0 76 24 0.8 1 1 1 2 1 2 1 1 1 2 2 2 2 2 1 I 
58  1 2 2 18.0 7.6 8000 61 30 3 0 97 18 0.9 1 2 2 2 1 2 1 2 2 2 2 2 1 2 2 I 
59  1 1 2 11.5 7.8 10000 71 26 3 0 88 20 0.8 1 2 2 2 1 2 2 1 2 2 2 2 2 2 2 I 
60  1 1 2 16.0 8.4 9200 70 28 2 0 70 32 0.9 0 1 1 1 1 2 2 2 1 2 2 2 2 2 2 I 
61 ATT 1 1 2 19.14 7 8400 72 26 2 0 105 26 0.9 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 II 
62 ATT 2 2 2 14.56 8 8200 64 28 6 2 114 60 1.3 1 1 1 1 1 1 1 2 2 1 2 2 2 2 2 II 
63 OHA 1 2 2 19.10 9.3 8600 76 22 2 0 310 31 1.2 1 2 2 2 2 2 2 2 1 2 2 1 2 2 2 I 
64 --- 2 1 2 18.70 10.2 9900 75 23 2 0 82 32 0.8 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 I 
65 ATT 1 2 2 16.79 10.40 7600 70 30 0 0 81 48 1.7 1 1 1 1 1 1 1 1 1 1 2 2 2 1 2 II 
66 --- 1 2 2 16.00 8.2 5500 68 30 2 0 88 44 1.2 1 2 2 1 1 1 1 2 2 2 2 2 1 2 2 I 
67 ATT 2 1 2 19.50 10.2 12500 82 16 2 0 116 41 1 1 1 1 2 1 2 1 2 1 2 2 2 2 1 2 II 
68 --- 2 1 2 18.00 11.0 7600 68 30 2 0 72 54 1.3 1 2 2 2 2 2 2 2 1 2 2 1 1 2 2 I 
69 OHA 1 2 2 29.00 7.80 7200 73 25 2 0 100 92 1.9 2 2 2 2 2 2 2 2 2 2 2 1 1 2 2 I 
70 --- 1 2 2 14.10 8.00 11000 76 22 2 0 100 22 0.8 1 1 1 1 1 1 1 1 1 2 2 2 2 2 1 I 
71 --- 2 2 2 17.90 11.00 10000 82 16 2 0 35 50 1.1 2 2 2 2 2 2 2 2 1 2 1 2 2 2 2 I 
72 ASA   B block 2 2 2 18.80 
10.8
0 11700 80 18 2 0 60 27 1.0 2 1 2 2 1 2 2 2 1 2 2 2 2 2 2 I 
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73 --- 1 2 2 17.70 10.20 8800 76 22 2 0 105 17 0.6 1 1 1 2 1 2 1 1 1 2 2 2 2 2 2 I 
74 OHA 1 2 2 19.50 8.0 7500 75 25 1 0 365 22 0.9 1 1 1 2 1 2 1 1 1 2 1 2 2 2 2 I 
75 OHA 1 2 2 22.60 7.0 7500 69 30 1 0 214 33 0.8 1 1 1 1 1 1 1 2 1 2 2 2 2 1 2 I  
76 --- 1 2 2 17.50 8 7600 82 18 0 0 90 27 0.7 1 1 1 2 2 1 1 1 1 2 2 2 1 2 2 I 
77 --- 1 2 2 10.70 9.2 8900 66 32 2 0 90 56 1.5 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 I 
78 --- 2 1 2 17.0 9.6 8600 59 35 6 0 69 43 0.7 1 2 2 2 1 2 1 2 2 2 2 2 2 2 2 I 
79 OHA 1 2 2 16.1 9.6 10500 71 26 3 0 310 22 0.9 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 I 
80 --- 1 2 2 21.0 8.8 10000 83 15 2 0 86 24 0.8 1 2 2 1 1 1 1 1 1 2 2 2 1 2 2 I 
81 ATT 2 2 2 22.0 11.6 7600 76 22 2 0 90 20 0.9 1 2 2 2 1 2 1 2 2 2 2 2 2 1 2 I 
82 ATT 1 1 2 19.1 10.6 11000 82 17 1 0 144 28 0.8 1 1 1 1 1 1 1 1 1 2 2 2 1 2 2 II 
83 --- 1 1 2 19.0 7.0 8600 66 32 2 0 93 28 0.8 1 1 1 2 1 2 1 1 1 1 2 2 1 2 2 I 
84 --- 1 1 2 18.0 8.2 9200 77 21 1 0 83 38 0.1 1 2 2 1 2 2 1 1 1 1 2 2 2 2 2 II 
85 --- 2 1 1 16.1 10 8500 60 38 2 0 120 75 1.3 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 III 
86 --- 1 1 2 16.4 9 9000 67 30 3 0 90 20 0.6 1 1 1 2 1 2 2 1 2 2 1 2 2 2 2 I 
87 OHA 2 1 2 19.5 9.6 10200 78 20 2 0 179 25 0.7 1 1 1 1 1 1 1 1 1 2 2 2 22 2 1 I 
88 --- 1 2 2 16.2 10.2 10500 80 17 2 0 90 20 0.7 1 1 1 2 1 2 1 1 1 2 2 2 2 2 2 I 
89 Anti.H7 1 1 1 21.2 8.4 8900 78 20 2 0 78 18 0.8 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 III 
90 OHA 2 1 2 21.0 11.2 9600 67 22 1 0 375 29 0.9 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 I 
